Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cardiac-selective sodium current inhibitor discovered at Gilead Sciences

Aug. 25, 2014

Candidate antidepressant mGlu2 and 3 receptor antagonists identified at Lilly

Aug. 25, 2014

WNT-974, a porcupine inhibitor targeting Wnt signaling in clinical testing

Aug. 25, 2014

Potential AD treatment activates TGF-beta signaling pathway in the brain

Aug. 22, 2014

AM-9514, a GK activator with good pharmacokinetic profile in vivo

Aug. 22, 2014

VX-787, first-in-class PB2 influenza polymerase inhibitor

Aug. 22, 2014

A potent mGluR5 PAM shows promise in rodent cognition models

Aug. 22, 2014

Novel pyridones inhibit T790M double mutant EGFR

Aug. 21, 2014

LC-MS/MS assay can detect vitamin B12 deficiency

Aug. 21, 2014

In vivo results reveal potent antitumor activity for the novel pan-Notch inhibitor BMS-986115

Aug. 21, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...